ERBA, PAOLA ANNA
 Distribuzione geografica
Continente #
NA - Nord America 14.629
AS - Asia 6.664
EU - Europa 5.616
SA - Sud America 1.558
AF - Africa 277
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 11
Totale 28.772
Nazione #
US - Stati Uniti d'America 14.225
CN - Cina 1.943
IT - Italia 1.852
SG - Singapore 1.599
HK - Hong Kong 1.457
BR - Brasile 1.278
SE - Svezia 1.002
DE - Germania 651
VN - Vietnam 596
BG - Bulgaria 525
GB - Regno Unito 397
CA - Canada 300
TR - Turchia 257
RU - Federazione Russa 238
UA - Ucraina 210
FI - Finlandia 195
KR - Corea 161
IN - India 150
AT - Austria 100
AR - Argentina 96
FR - Francia 90
CH - Svizzera 85
CI - Costa d'Avorio 83
BD - Bangladesh 73
NL - Olanda 69
ID - Indonesia 63
EC - Ecuador 54
MX - Messico 54
JP - Giappone 49
ZA - Sudafrica 47
IQ - Iraq 44
SA - Arabia Saudita 38
SN - Senegal 33
ES - Italia 32
BE - Belgio 31
PL - Polonia 31
TH - Thailandia 31
UZ - Uzbekistan 31
CO - Colombia 30
IR - Iran 27
PK - Pakistan 26
PY - Paraguay 25
CL - Cile 24
MA - Marocco 23
VE - Venezuela 21
CZ - Repubblica Ceca 18
NG - Nigeria 17
UY - Uruguay 16
AU - Australia 14
DZ - Algeria 13
KE - Kenya 13
IE - Irlanda 12
EG - Egitto 10
IL - Israele 10
LT - Lituania 10
PT - Portogallo 10
BJ - Benin 9
JM - Giamaica 9
PE - Perù 9
TN - Tunisia 9
TT - Trinidad e Tobago 9
TW - Taiwan 9
CR - Costa Rica 8
GH - Ghana 8
JO - Giordania 8
NP - Nepal 8
PH - Filippine 8
AE - Emirati Arabi Uniti 7
EU - Europa 7
GR - Grecia 7
HU - Ungheria 7
KW - Kuwait 7
LK - Sri Lanka 7
MY - Malesia 7
DK - Danimarca 6
KZ - Kazakistan 6
OM - Oman 6
RO - Romania 6
AL - Albania 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
SK - Slovacchia (Repubblica Slovacca) 5
AF - Afghanistan, Repubblica islamica di 4
AM - Armenia 4
AZ - Azerbaigian 4
LB - Libano 4
PA - Panama 4
RS - Serbia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
GA - Gabon 3
HR - Croazia 3
KG - Kirghizistan 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
BZ - Belize 2
Totale 28.736
Città #
Ashburn 1.473
Hong Kong 1.445
Woodbridge 1.376
Fairfield 1.318
Dallas 1.251
Houston 998
Singapore 971
Ann Arbor 916
Chandler 742
Santa Clara 647
Milan 576
Seattle 537
Shanghai 535
Sofia 523
Wilmington 469
Cambridge 425
New York 376
Beijing 353
Princeton 300
Jacksonville 277
Boardman 254
Ottawa 225
Lawrence 214
Los Angeles 195
Hefei 190
Medford 174
London 166
Seoul 153
Bremen 139
Nanjing 136
Serra 135
Izmir 130
Ho Chi Minh City 124
Dong Ket 114
Des Moines 112
Dearborn 104
São Paulo 97
Istanbul 93
Munich 92
Pisa 88
Buffalo 86
Abidjan 83
Vienna 83
Redondo Beach 81
Bern 75
Hanoi 73
Florence 72
San Diego 68
Redwood City 62
Nanchang 58
Jüchen 52
Rome 52
Rio de Janeiro 44
Council Bluffs 43
Frankfurt am Main 43
Hebei 43
Turku 40
Ogden 39
Chicago 38
Fuzhou 37
Nuremberg 35
Tokyo 35
Kunming 34
Shenyang 34
The Dalles 34
Columbus 33
Dakar 33
Belo Horizonte 31
Boulder 30
Düsseldorf 30
Johannesburg 27
Brussels 26
Quanzhou 26
Guangzhou 25
Tashkent 25
Warsaw 25
Changsha 24
Norwalk 24
Lancaster 23
Curitiba 22
Pune 21
Brasília 20
Montreal 20
Bangkok 19
Jiaxing 19
Baghdad 18
Dhaka 18
Guayaquil 18
Toronto 18
Campinas 17
Chennai 17
Falls Church 17
Porto Alegre 17
Salvador 16
Verona 16
Hangzhou 15
Washington 15
Auburn Hills 14
Gallarate 14
Genoa 14
Totale 20.534
Nome #
Diagnostic applications of nuclear medicine: Multiple myeloma 727
International Impact of COVID-19 on the Diagnosis of Heart Disease 381
Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID) 266
[F-18]FMCH intratumor heterogeneity analysis by advanced texture analysis in patients with prostate cancer recurrence 257
Worldwide Disparities in Recovery of Cardiac Testing 1 Year Into COVID-19 253
Nuclear medicine imaging of bone infections 222
New approaches for imaging and therapy of solid cancer 220
Radiolabelled leucocyte scintigraphy versus conventional radiological imaging for the management of late, low-grade vascular prosthesis infections. 217
[18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: Preliminary results 215
Antioxidants: a tale of two stories. 211
Prevalence of hypovitaminosis D and predictors of vitamin D status in Italian healthy adolescents 211
Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World 200
Towards the use of nanoparticles in cancer therapy and imaging 199
ED-B fibronectin expression is a marker of epithelial-mesenchymal transition in translational oncology 198
Lymphoscintigraphy for the Differential Diagnosis of Peripheral Edema and Intracavitary Lymph Effusion 191
Design and fabrication of novel polymeric biodegradable stents for small caliber blood vessels by computer-aided wet-spinning 189
Detecting the vulnerable carotid plaque: the Carotid Artery Multimodality imaging Prognostic study design 187
Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETs 181
pH-responsive carboxymethylcellulose nanoparticles for 68Ga-WBC labeling in PET imaging 181
3-Iodothyronamine as a novel endogenous chemical messenger: tissue distribution and catabolism 180
Body composition and metabolic profile in women with complete androgen insensitivity syndrome. 176
Postmeeting summary on the round table discussion at the Seventh International Symposium on Technetium in Chemistry and Nuclear Medicine held in Bressanone, Italy on Sept 6-9, 2006 175
3-Iodothyronamine as a Novel Endogenous Chemical Messenger: Tissue Distribution and Catabolism. 175
Clinical Applications of Nuclear Medicine: Multiple Myeloma 175
Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies. 174
18F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer 174
Dosimetry for nonuniform activity distributions: a method for the calculation of 3D absorbed-dose distribution without the use of voxel S-values, point kernels, or Monte Carlo simulations. 170
Radionuclide Evaluation of Gaucher Disease 169
Stereotactic body radiotherapy of bone metastases in oligometastatic disease: prognostic factors of oncologic outcomes 169
Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution. 168
Combination of DWI/DCE-MRI and [18F]FECH PET/CT in Patients with Biochemical Relapse of Prostate Cancer: Impact on Treatment Decision Making, EANM’14, Annual Congress of the European Association of Nuclear Medicine 168
Retrospective analysis of the association of nodular goiter with primary and secondary hyperparathyroidism 167
An Improved Protocol for Increasing the Potential of Lymphoscintigraphy in patients with Peripheral Lymphedema 167
Chromogranin-A as a serum marker for neuroendocrine tumors: comparison with neuron-specific enolase and correlation with immunohistochemical findings 167
From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial 164
Usefulness of phalangeal quantitative ultrasound in identifying reduced bone mineral status and increased fracture risk in adolescents with Turner syndrome. 162
Lymphoscintigraphic and intraoperative detection of the sentinel lymph node in breast cancer patients: the nuclear medicine perspective 161
Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. 161
Clinical feasibility of two-step Streptavidin/111In-Biotin scintigraphy in patients with suspected vertebral osteomyelitis 159
Radiolabeled somatostatin analogues therapy in advanced neuroendocrine tumors: a single centre experience. 158
Comparison of [18F]FDG PET/CT and 99mTc-HMPAO-labeled leukocyte (99mTc-HMPAO-WBC) SPECT/CT in patients with cardiovascular device infection. Eanm'14 158
Diagnostic Applications of Nuclear Medicine: Leukemias 158
Improving women's health in low-income and middle-income countries. Part II: The needs of diagnostic imaging 158
Radiotracers for fungal infection imaging 156
2015 ESC Guidelines for the management of infective endocarditis 156
[18F]FDG-PET/CT patterns of bone metastases in lung cancer 155
[18F]Fluorocholine PET/CT-guided stereotactic body radiotherapy in patients with recurrent oligometastatic prostate cancer 155
Radioimmunotherapy of non-Hodgkin's lymphoma: molecular targeting and novel agents 154
Pathophysiology of lymphatic circulation in different disease conditions 153
The "3M" Approach to Cardiovascular Infections: Multimodality, Multitracers, and Multidisciplinary 153
Radiopharmaceuticals for Radioguided Surgery 151
Influence of different chelators on the radiochemical properties of a 68-Gallium labelled bombesin analogue. 151
Radionuclide Therapy of Leukemias 150
EP-1568 Long-term results of [18F] Fluorocholine PET/CT guided SBRT in patients with prostate cancer 150
Fraibility of Bone Marrow Scintigraphy with 99mTc-Sestamibi in the evaluation of Patients with Multiple Mieloma: Initial one-Center Experience 148
Tissue imaging of (111)in-oxine labeled human endothelial progenitor cells in muscle ischemia and inflammation 148
Role of positron emission tomography in diagnosis and follow-up of pancreatic lesions 147
Body Mass Index and Body Composition in Adolescents Treated with Gonadotropin-Releasing Hormone Analogue Triptorelin Depot for Central Precocious Puberty: Data at Near Final Height 147
PET/CT and PET/MRI in Neurology: Infection/Inflammation 147
Differentiated thyroid cancer: A new perspective with radiolabeled somatostatin analogues for imaging and treatment of patients 146
PET/MRI in Infection and Inflammation 146
Homing of (111)ln-oxine radiolabelled endothelial progenitor cells in ischemic or inflammed mice hindlimbs: Differential cytokine and chemokine profile 145
Other Imaging Modalities in Infective Endocarditis Diagnosis 145
Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study. 144
Altre tecniche diagnostiche 143
Radiosynthesis of 68Ga-labelled DOTA-biocytin (68Ga-r-BHD) and assessment of its pharmaceutical quality for clinical use. 143
Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients 143
Diagnostic performances of [18f]fluorocholine positron emission tomography in brain tumors 142
Methodological Aspects of Lymphoscintigraphy: Radiopharmaceuticals and Instrumentation 141
Added value of 99mTc-HMPAO-labeled leukocyte SPECT/CT imaging in the characterization and management of patients with infectious endocarditis 141
A pilot clinical trial on scintimammography (SMM) with 99mTc-D-Glucaric Acid in patients with breast cancer 139
Peripheral dual-phase bicompartmental lymphoscintigraphy to localize the site of lymphatic obstruction and guide therapeutic management of patients 139
Nuclear Medicine Imaging and Cardiotoxicity 139
ASSESSMENT OF TISSUE DISTRIBUTION OF HUMAN ENDOTHELIAL PROGENITOR CELLS BY RADIOACTIVE LABELING IN A MODEL OF HINDLIMB ISCHEMIA 139
Preliminary experience with somatostatin receptor scintigraphy for neuroedocrine characterization of patients with hormone-refractory prostatic cancer 138
99mTc-Sestamibi Scintigraphy to Monitor the Long-Term Efficacy of Enzyme Replacement Therapy on Bone Marrow Infiltration in Patients with Gaucher Disease. 138
Selective homing of radioactive labeled endothelial progenitor cells in ischaemic hindlimbs 137
Comparative Diagnostic Accuracy of Whole-Body [18 F]FDG-PET and 99mTc-MDP Bone Scintigraphy in the Identification of Bone Metastasis 136
Differential diagnosis of dementia with Lewy Bodies and Alzheimer’s disease by scintigraphic evaluaton of dopaminergic degeneration and selective regional cerebral blood flow impairment 135
Tecniche diagnostiche per lo studio dell’apparato osteo-articolare 135
Standardization of MRI and Scintigraphic Scores for Assessing the Severity of Bone Marrow Involvement in Adult Patients With Type 1 Gaucher Disease 135
[18F]FDG-PET/CT evaluation of adrenal lesions in patients with non-small-cell lung cancer 134
Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of 131I-L19SIP in a prostate cancer patient 134
Evaluation of[F-18] NaF uptake in symptomatic and asymptomatic carotid artery plaques and determination of predictive pattern of vulnerable plaque : preliminary results 132
Role of Multimodal Imaging in Patients With Suspected Infections After the Bentall Procedure 131
Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients 131
TISSUE DISTRIBUTION OF RADIOLABELED HUMAN ENDOTHELIAL PROGENITOR CELLS IN NORMAL MICE AND IN A MODEL OF PERIOPHERAL SKELETAL MUSCLE ISCHEMIA AND INFLAMMATION 130
Nonorthopedic or Cardiovascular Implantable Device Infection 130
Somatostatin receptor positron emission tomography/computed tomography imaging in Merkel cell carcinoma 130
CERENKOV LUMINESCENCE IMAGING IN PULMONARY AND HEPATIC METASTASECTOMY 130
Tecniche diagnostiche per lo studio del sistema linfatico 129
18-FDG PET for large vessel vasculitis diagnosis and follow-up 129
Multidrug resistance in cancer: Its mechanism and its modulation 127
Scintimammography with 99mTc-D-Glucaric acid in patients with breast cancer: preliminary results 126
Study of skin vasomotion during phollicular and luteal phase in young healthy women 126
The role of imaging in the diagnosis of recurrence of primary seminal vesicle adenocarcinoma 126
Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen? 126
Infective Endocarditis and Cardiovascular Implantable Electronic Device Infection 124
Detection of osteomyelitis in the diabetic foot by imaging techniques: A systematic review and meta-analysis comparing mri, white blood cell scintigraphy, and FDG-PET 124
Low dose” 99mTc-Sestamibi for radioguided surgery of primary hyperparathyroidism 123
Totale 16.671
Categoria #
all - tutte 81.560
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.560


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.063 0 0 0 0 0 75 70 165 199 92 159 303
2021/20222.581 38 105 107 167 501 370 94 119 170 73 159 678
2022/20232.910 405 449 223 333 263 334 46 209 400 20 172 56
2023/20242.214 281 248 267 172 347 357 83 59 33 34 81 252
2024/20256.661 57 252 102 351 488 536 585 407 669 924 732 1.558
2025/20265.073 525 1.150 1.493 1.118 641 146 0 0 0 0 0 0
Totale 29.228